clinical trials

Rehab Centers: Suprascapular Nerve: Is It Important in Cuff Pathology?

Suprascapular nerve: is it important in cuff pathology?

Filed under: Rehab Centers

Adv Orthop. 2012; 2012: 516985
Shi LL, Freehill MT, Yannopoulos P, Warner JJ

Suprascapular nerve and rotator cuff function are intimately connected. The incidence of suprascapular neuropathy… Continue reading

Drug and Alcohol Rehabilitation: Biomedical Applications of Dipeptides and Tripeptides.

Biomedical applications of dipeptides and tripeptides.

Filed under: Drug and Alcohol Rehabilitation

Biopolymers. 2012; 98(4): 288-93
Santos S, Torcato I, Castanho MA

Peptides regulate many physiological processes, acting at some sites as endocrine or paracrine signals and at others… Continue reading

Addiction Rehab: Coinciding Revolutions: How Discovery of Non-Coding DNA and RNA Can Change Our Understanding of Addiction.

Coinciding revolutions: how discovery of non-coding DNA and RNA can change our understanding of addiction.

Filed under: Addiction Rehab

Front Genet. 2012; 3: 271
Pietrzykowski AZ

HubMed – addiction

 

The role of orexins/hypocretins in alcohol use and abuse:… Continue reading

Canada Clamps Down on Access to Drug Safety Data.

Canada clamps down on access to drug safety data.

Filed under: Drug and Alcohol Rehabilitation

Lancet. 2012 Nov 24; 380(9856): 1805
Webster PC

HubMed – drug

 

Spinosad: An effective and safe pediculicide.

Filed under: Drug and Alcohol Rehabilitation… Continue reading

Linagliptin for Type 2 Diabetes Mellitus: A Review of the Pivotal Clinical Trials.

Linagliptin for type 2 diabetes mellitus: a review of the pivotal clinical trials.

Filed under: Drug and Alcohol Rehabilitation

Ther Adv Endocrinol Metab. 2012 Aug; 3(4): 113-24
McGill JB

Patients with type 2 diabetes mellitus (T2DM) frequently require multiple… Continue reading

[The Participation of the Nutritionist in Primary Health Care in a Large Urban Center].

[The participation of the nutritionist in Primary Health Care in a large urban center].

Filed under: Rehab Centers

Cien Saude Colet. 2012 Dec; 17(12): 3289-300
Cervato-Mancuso AM, Tonacio LV, Silva ER, Vieira VL

Nutritionists are important professionals for ensuring… Continue reading

Nicotine Receptor Partial Agonists for Smoking Cessation.

Nicotine receptor partial agonists for smoking cessation.

Filed under: Addiction Rehab

Sao Paulo Med J. 2012; 130(5): 346-7
Cahill K, Stead LF, Lancaster T, Polonio IB

Nicotine receptor partial agonists may help people to stop smoking by a combination… Continue reading

Mindfulness and Bodily Distress.

Mindfulness and bodily distress.

Filed under: Depression Treatment

Dan Med J. 2012 Nov; 59(11): B4547
Fjorback LO

We have created a mindfulness approach to treat patients who experience multiple, persistent, and disabling physical symptoms that cannot be explained by a well-defined medical or surgical condition. Randomized controlled trials in this area are few, and research is hampered by the lack of clear definitions. Bodily distress syndrome (BDS) or bodily stress is an empirically defined definition unifying various conditions such as fibromyalgia, chronic fatigue syndrome, and somatization disorder. In the present PhD, we explored whether patients suffering from BDS may be committed to mental training in the form of mindfulness therapy, which is a mindfulness program specifically targeted patients suffering from BDS. The theoretical model for including mindfulness training in the treatment of BDS is based on identified neurobiological impairments in these patients and the neurobiological improvements that mindfulness training may offer. BDS is a major public health issue possibly associated with the pathology of the immuno-endocrine and autonomic nervous system. BDS patients are often stigmatized, and effective treatment is rarely delivered, which leaves these patients isolated, left by themselves, vulnerable to potentially harming medical and/or alternative treatments. Accordingly, there is a need for non-harming practical tools that patients can learn to master so that they can improve the ability to take responsibility for their own health and wellbeing. Mindfulness-Based Stress Reduction (MBSR) is a group program that employs mindfulness practice to alleviate suffering associated with physical, psychosomatic, and psychiatric disorders. Mindfulness-Based Cognitive Therapy (MBCT) is designed to prevent depressive relapse. Paper I and II present systematic literature reviews only of randomized controlled trials on MBSR and MBCT. The effect of MBSR has been explored on fibromyalgia in three studies, none of them showed convincing results, but gave some indications as to improvement. The reviews recommended MBSR as a useful method for improving mental health; however, lack of long-term follow-up and active control groups are limitations in most studies. MBCT was recommended as a tool for preventing depressive relapse in recovered, recurrently depressed patients, but the implication of MBSR and MBCT is problematic, especially due to the lack of well educated mindfulness teachers. We combined MBSR with cognitive behavioral therapy, CBT, specifically targeted BDS. Paper III provides original data from 119 patients enrolled in a randomized clinical trial, mindfulness therapy for BDS. The randomized controlled trial indicates that BDS patients are capable of and willing to engage in mindfulness therapy. This thesis showed that mindfulness therapy can safely and successfully engage BDS patients in mindfulness practice. Since individual CBT and psychiatric consultation have previously been found to have positive outcomes for BDS patients, we compared mindfulness therapy to an active control group entitled specialized treatment in which an individual treatment was planned in collaboration between the patient and an MD specialized in BDS, CBT, and psychiatry. Mindfulness therapy was comparable to specialized treatment in improving the quality of life and the symptoms of the patients with BDS at 15-month follow-up. For primary outcome physical health (PCS) at 15-month follow-up, different developments over time for the two treatment groups could not be established (F(3,2674) = 1.51, p = 0.21). However, in the mindfulness therapy group, PCS significant changed at the end of treatment and this change remained at 15-month follow-up, whereas no significantly change was seen in the specialized treatment group until at the 15-month follow-up. In the mindfulness therapy group, 26%; CI: 14-38 reported a marked improvement (> 1 SD) at the end of treatment compared with 10%; CI: 2-18 in the specialized treatment group. This amounts to a statistically… Continue reading

Drug and Alcohol Rehabilitation: Durability of Improvement in Posttraumatic Stress Disorder Symptoms and Absence of Harmful Effects or Drug Dependency After 3,4-Methylenedioxymethamphetamine-Assisted Psychotherapy: A Prospective Long-Term Follow-Up Study.

Durability of improvement in posttraumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study.

Filed under: Drug and Alcohol Rehabilitation

J Psychopharmacol. 2012 Nov 20;
Mithoefer MC, Wagner MT,… Continue reading

Brain-Penetrant Tetrahydronaphthalene Thromboxane A2-Prostanoid (TP) Receptor Antagonists as Prototype Therapeutics for Alzheimer’s Disease.

Brain-Penetrant Tetrahydronaphthalene Thromboxane A2-Prostanoid (TP) Receptor Antagonists as Prototype Therapeutics for Alzheimer’s Disease.

Filed under: Drug and Alcohol Rehabilitation

ACS Chem Neurosci. 2012 Nov 21; 3(11): 928-40
Soper JH, Sugiyama S, Herbst-Robinson K, James MJ, Wang X, Trojanowski JQ,… Continue reading